Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Net Sales
632.63
398.25
214.52
Other Operating Income
0.00
0.00
0.00
Total Operating income
632.63
398.25
214.52
Raw Material Cost
114.27
91.64
31.96
Purchase of Finished goods
137.32
89.83
70.30
(Increase) / Decrease In Stocks
0.07
-0.76
3.88
Employee Cost
112.25
60.37
35.46
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
100.40
67.47
31.32
Total Expenditure (Excl Depreciation)
464.31
308.55
172.92
Operating Profit (PBDIT) excl Other Income
168.32
89.70
41.60
Other Income
47.06
19.26
2.82
Operating Profit (PBDIT)
215.38
108.96
44.42
Interest
25.03
21.55
9.45
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
190.35
87.41
34.97
Depreciation
31.25
16.84
10.02
Profit Before Tax
159.10
70.57
24.95
Tax
37.58
12.23
-7.76
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
121.52
58.34
32.71
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
121.52
58.34
32.71
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-6.16
0.22
-1.26
Other related items
0.00
0.00
0.00
Consolidated Net Profit
115.36
58.56
31.45
Equity Capital
46.05
46.05
30.51
Face Value
10.0
10.0
10.0
Reserves
887.55
740.13
173.76
Earnings per share (EPS)
25.05
12.72
10.31
Diluted Earnings per share
26.39
16.12
12.21
Operating Profit Margin (Excl OI)
26.61%
22.52%
19.39%
Gross Profit Margin
30.09%
21.95%
16.3%
PAT Margin
19.21%
14.65%
15.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 58.85% vs 85.65% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 96.99% vs 86.20% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 87.65% vs 115.62% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 16.15% vs 128.04% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Senores Pharma. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
632.63
1,879.17
-1,246.54
-66.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
632.63
1,879.17
-1,246.54
-66.33%
Raw Material Cost
114.27
23.60
90.67
384.19%
Purchase of Finished goods
137.32
0.00
137.32
(Increase) / Decrease In Stocks
0.07
0.00
0.07
Employee Cost
112.25
118.03
-5.78
-4.90%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
22.66
-22.66
-100.00%
Selling and Distribution Expenses
0.00
69.48
-69.48
-100.00%
Other Expenses
100.40
46.64
53.76
115.27%
Total Expenditure (Excl Depreciation)
464.31
280.41
183.90
65.58%
Operating Profit (PBDIT) excl Other Income
168.32
1,598.76
-1,430.44
-89.47%
Other Income
47.06
10.95
36.11
329.77%
Operating Profit (PBDIT)
215.38
1,609.71
-1,394.33
-86.62%
Interest
25.03
34.13
-9.10
-26.66%
Exceptional Items
0.00
-12.36
12.36
100.00%
Gross Profit (PBDT)
190.35
1,563.22
-1,372.87
-87.82%
Depreciation
31.25
10.21
21.04
206.07%
Profit Before Tax
159.10
1,553.01
-1,393.91
-89.76%
Tax
37.58
-0.19
37.77
19,878.95%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
121.52
1,553.20
-1,431.68
-92.18%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
121.52
1,553.20
-1,431.68
-92.18%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-6.16
0.00
-6.16
Other related items
0.00
0.00
0.00
Consolidated Net Profit
115.36
1,553.20
-1,437.84
-92.57%
Equity Capital
46.05
32.45
13.60
41.91%
Face Value
10.00
1.00
0.00
Reserves
887.55
1,306.37
-418.82
-32.06%
Earnings per share (EPS)
25.05
47.86
-22.81
-47.66%
Diluted Earnings per share
26.39
47.86
-21.47
-44.86%
Operating Profit Margin (Excl OI)
26.61%
4,083.68%
0.00
-4,057.07%
Gross Profit Margin
30.09%
3,992.90%
0.00
-3,962.81%
PAT Margin
19.21%
3,967.31%
0.00
-3,948.10%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 632.63 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 58.85% vs 85.65% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 115.36 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 96.99% vs 86.20% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 168.32 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 87.65% vs 115.62% in Mar 2025
Annual - Interest
Interest 25.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 16.15% vs 128.04% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.61%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
